(Q41245830)

28 September 2017

Cost-effectiveness of low-molecular-weight heparin in the treatment of proximal deep vein thrombosis (English)

1 reference

28 September 2017

0 references

C A Estrada

1

1 reference

28 September 2017

C J Mansfield

series ordinal

2

1 reference

28 September 2017

G R Heudebert

series ordinal

3

1 reference

28 September 2017

1 February 2000

1 reference

Journal of General Internal Medicine

28 September 2017

1 reference

28 September 2017

15

1 reference

28 September 2017

2

1 reference

28 September 2017

108-115

1 reference

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Low-molecular-weight heparins

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

A 14-year study of heparin-induced thrombocytopenia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Management of venous thromboembolism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Cost-effectiveness analysis of various strategies in the diagnostic management of pulmonary embolism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Heparin-associated thrombocytopenia.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Optimal management of suspected lower-extremity deep vein thrombosis. An evaluation with cost assessment of 24 management strategies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Diagnostic and therapeutic strategies of white clot syndrome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Economic analysis alongside clinical trials. Bias in the assessment of economic outcomes.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Cost of Long-Term Complications of Deep Venous Thrombosis of the Lower Extremities: An Analysis of a Defined Patient Population in Sweden

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Fatal pulmonary embolism in cancer patients: is heparin prophylaxis justified?

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Hospitalization and case fatality for pulmonary embolism in the twin cities: 1979-1984.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety

17 June 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.03349.X

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.03349.X

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.03349.X

A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.03349.X

Risk of fatal pulmonary embolism in patients with treated venous thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.03349.X

Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.03349.X

Low-molecular-weight heparin in the treatment of patients with venous thromboembolism

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Cost effectiveness of diagnosis of deep vein thrombosis in symptomatic patients.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495337

Management and prevention of thromboembolic events in patients with cancer-related hypercoagulable states

19 August 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.03349.X

The Long-Term Clinical Course of Acute Deep Venous Thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.03349.X

21 January 2018

Venous thromboembolism

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.03349.X

Antithrombotic therapy for venous thromboembolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.03349.X

Hemorrhagic complications of anticoagulant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.03349.X

Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.03349.X

The clinical course of pulmonary embolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.03349.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.03349.X

Trends in pulmonary embolism mortality in the US elderly population: 1984 through 1991

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.03349.X

Economic evaluation of the use of nadroparin in the treatment of deep-vein thrombosis in Switzerland

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.03349.X

The economics of general thromboembolic prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.03349.X

Cost-effectiveness of pulmonary embolism diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.03349.X

Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group

21 January 2018

1 reference

12 December 2020

Cost effectiveness and ease of administration of low molecular weight heparin in deep vein thrombosis

1 reference

12 December 2020

[Health care economics evaluation of inpatient treatment of venous thrombosis with unfractionated heparin versus subcutaneous low molecular weight heparin at home]

1 reference

12 December 2020

Pharmacoeconomic model of enoxaparin versus heparin for prevention of deep vein thrombosis after total hip replacement

1 reference

12 December 2020

10.1046/J.1525-1497.2000.03349.X

Identifiers

DOI

1 reference

Dimensions Publication ID

28 September 2017

0 references

1 reference

28 September 2017

PubMed publication ID

10672114

1 reference